This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Shasun Pharmaceuticals Limited
Shasun Pharmaceuticals Limited, often referred to simply as Shasun, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 1987, the company has made significant strides in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, catering to both domestic and international markets. With a strong presence in regions such as North America, Europe, and Asia, Shasun focuses on key therapeutic areas including anti-infectives, cardiovascular, and central nervous system disorders. The company is recognised for its commitment to quality and innovation, offering a diverse portfolio of products that stand out for their efficacy and safety. Shasun's dedication to research and development has positioned it as a trusted partner in the pharmaceutical sector, achieving notable milestones in regulatory approvals and collaborations. As a result, Shasun Pharmaceuticals Limited continues to enhance its market position, contributing to global health solutions.
DitchCarbon Score
How does Shasun Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shasun Pharmaceuticals Limited's score of 38 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shasun Pharmaceuticals Limited, headquartered in India, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Strides Pharma Science Limited, which may influence its climate commitments and emissions reporting. As of now, Shasun Pharmaceuticals has not set any documented reduction targets or climate pledges. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of formalising its climate strategy. Given the context of the pharmaceutical industry, it is essential for companies like Shasun Pharmaceuticals to develop robust climate commitments and emissions reduction strategies to align with global sustainability goals. The cascading data from Strides Pharma Science Limited may provide insights into broader corporate climate initiatives, but specific details regarding Shasun's own emissions and targets remain unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 6,168,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 19,385,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shasun Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
